These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 17194172

  • 41. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study.
    Thomsen RW, Nicolaisen SK, Hasvold P, Sanchez RG, Pedersen L, Adelborg K, Egstrup K, Egfjord M, Sørensen HT.
    Nephrol Dial Transplant; 2018 Sep 01; 33(9):1610-1620. PubMed ID: 29177463
    [Abstract] [Full Text] [Related]

  • 42. Drug-drug interactions among elderly patients hospitalized for drug toxicity.
    Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA.
    JAMA; 2003 Apr 02; 289(13):1652-8. PubMed ID: 12672733
    [Abstract] [Full Text] [Related]

  • 43. Trimethoprim-associated hyperkalaemia: a systematic review and meta-analysis.
    Faré PB, Memoli E, Treglia G, Bianchetti MG, Milani GP, Marchisio P, Lava SAG, Janett S.
    J Antimicrob Chemother; 2022 Sep 30; 77(10):2588-2595. PubMed ID: 36018069
    [Abstract] [Full Text] [Related]

  • 44. Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study.
    Pratt N, Roughead EE, Ryan P, Gilbert AL.
    Drugs Aging; 2010 Jan 01; 27(1):63-71. PubMed ID: 20030433
    [Abstract] [Full Text] [Related]

  • 45. [Prospective observational study of angiotensin converting enzyme inhibitors-induced hyperkalemia in hospitalized patients with chronic renal failure].
    Ben Mahmoud L, Ghozzi H, Kammoun K, Hakim A, Kharrat M, Ben Hmida M, Jarraya F, Sahnoun Z, Zeghal K, Hachicha J.
    Nephrol Ther; 2013 Apr 01; 9(2):98-102. PubMed ID: 23022289
    [Abstract] [Full Text] [Related]

  • 46. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 01; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 47. Hyperkalaemia in patients in hospital.
    Moore ML, Bailey RR.
    N Z Med J; 1989 Oct 25; 102(878):557-8. PubMed ID: 2812582
    [Abstract] [Full Text] [Related]

  • 48. Influence of drugs and comorbidity on serum potassium in 15 000 consecutive hospital admissions.
    Henz S, Maeder MT, Huber S, Schmid M, Loher M, Fehr T.
    Nephrol Dial Transplant; 2008 Dec 25; 23(12):3939-45. PubMed ID: 18614817
    [Abstract] [Full Text] [Related]

  • 49. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T, Saito T, Miyai I, Nozaki S, Kang J.
    Rinsho Shinkeigaku; 2000 May 25; 40(5):439-45. PubMed ID: 11002725
    [Abstract] [Full Text] [Related]

  • 50. Clinical factors affecting serum potassium concentration in cardio-renal decompensation syndrome.
    Ueno H, Yoshimura M, Nakayama M, Yamamuro M, Nishijima T, Kusuhara K, Nagayoshi Y, Kojima S, Kaikita K, Sumida H, Sugiyama S, Ogawa H.
    Int J Cardiol; 2010 Jan 21; 138(2):174-81. PubMed ID: 18804879
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: Analysis of French data from the PROKALE multinational European study].
    Rossignol P, investigateurs de PROKALEUniversité de Lorraine, Inserm, Centre d'Investigations Cliniques - Plurithématique 14-33, and Inserm U1116, CHRU Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France..
    Nephrol Ther; 2021 Oct 21; 17(6):422-427. PubMed ID: 33994135
    [Abstract] [Full Text] [Related]

  • 53. Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.
    Yavin Y, Mansfield TA, Ptaszynska A, Johnsson K, Parikh S, Johnsson E.
    Diabetes Ther; 2016 Mar 21; 7(1):125-37. PubMed ID: 26758563
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.
    Kurnik D, Vesterman-Landes J, Bialik M, Katzir I, Lomnicky Y, Halkin H, Loebstein R.
    Clin Ther; 2011 Apr 21; 33(4):456-64. PubMed ID: 21635991
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Drug-induced hyperkalemia.
    Ponce SP, Jennings AE, Madias NE, Harrington JT.
    Medicine (Baltimore); 1985 Nov 21; 64(6):357-70. PubMed ID: 2865667
    [Abstract] [Full Text] [Related]

  • 59. Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals.
    Noize P, Bagheri H, Durrieu G, Haramburu F, Moore N, Giraud P, Galinier M, Pourrat J, Montastruc JL.
    Pharmacoepidemiol Drug Saf; 2011 Jul 21; 20(7):747-53. PubMed ID: 21438068
    [Abstract] [Full Text] [Related]

  • 60. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: "The Triple Whammy".
    Camin RM, Cols M, Chevarria JL, Osuna RG, Carreras M, Lisbona JM, Coderch J.
    Nefrologia; 2015 Jul 21; 35(2):197-206. PubMed ID: 26300514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.